Literature DB >> 22700219

Emerging anticarcinogenic effects of fluoxetine besides its role in the treatment of breast carcinomas.

Shailendra Kapoor1.   

Abstract

I read with great interest the recent article by Zhou et al. in a recent issue of your esteemed journal. The article is highly thought provoking. Interestingly, over the past few years, new data has emerged that reveals the emerging anticarcinogenic role of fluoxetine in systemic tumors besides breast carcinomas.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22700219     DOI： 10.1007/s13277-012-0430-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


  4 in total

1.  Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen.

Authors:  Mirit Argov; Rina Kashi; Dan Peer; Rimona Margalit
Journal:  Cancer Lett       Date:  2008-10-11       Impact factor: 8.679

2.  Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats.

Authors:  Vinicius Kannen; Tassiana Marini; Aline Turatti; Milene C Carvalho; Marcus L Brandão; Valquiria A P Jabor; Pierina S Bonato; Frederico R Ferreira; Dalila L Zanette; Wilson A Silva; Sérgio B Garcia
Journal:  Toxicol Lett       Date:  2011-04-29       Impact factor: 4.372

3.  Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells.

Authors:  Ting Zhou; Jingjing Duan; Yan Wang; Xin Chen; Ganping Zhou; Rongkan Wang; Liwu Fu; Feng Xu
Journal:  Tumour Biol       Date:  2012-05-02

4.  Fluoxetine induces apoptosis in ovarian carcinoma cell line OVCAR-3 through reactive oxygen species-dependent activation of nuclear factor-kappaB.

Authors:  Chung Soo Lee; Yun Jeong Kim; Eun Ra Jang; Wonyong Kim; Soon Chul Myung
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-29       Impact factor: 4.080
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.